Item | Cat. No. | Species | Species Reactivity | Type | Application |
Anti-IL-17a mAbs [Cnto7357](MABL-2038) | MABL-2038 | Engineer | Human | Recombinate | ELISA |
Anti-IL-17A mAbs [3D11](MABL-2037) | MABL-2037 | Engineer | Chicken | Recombinate | WB, ELISA |
Anti-IL-17A mAbs [1G8](MABL-2036) | MABL-2036 | Engineer | Chicken | Recombinate | WB, ELISA, FC |
Anti-IL-17 mAbs [MCAF5352A (Afasevikumab)](MABL-2035) | MABL-2035 | Engineer | Human | Recombinate | neutralize, SPR, Block, ELISA |
Anti-IL-17 mAbs [IL-17M70](MABL-2034) | MABL-2034 | Engineer | Human | Recombinate | SPR |
Anti-IL-17 mAbs [Antibody 7](MABL-2033) | MABL-2033 | Engineer | Dog, Human, Cynomolgus Monkey | Recombinate | crystallization, functional assays, in vivo, SPR, ELISA |
Anti-IL-16 mAbs [14.1](MABL-2032) | MABL-2032 | Engineer | Human | Recombinate | WB, ELISA, FC, IHC |
Anti-IL-15 mAbs [M4-7](MABL-2031) | MABL-2031 | Engineer | Human | Recombinate | neutralizing, WB, ELISA |
Anti-IL-13 mAbs [M1295](MABL-2030) | MABL-2030 | Engineer | Human | Recombinate | neutralize, therapeutic, ELISA |
Anti-IL-13 mAbs [DOM10-53-616](MABL-2029) | MABL-2029 | Engineer | Human, Rhesus Monkey, Cynomolgus Monkey | Recombinate | neutralize, ELISA |
Anti-IL-13 mAbs [CNTO607](MABL-2028) | MABL-2028 | Engineer | Human | Recombinate | neutralize, ELISA |
Anti-IL-13 mAbs [6A1](MABL-2027) | MABL-2027 | Engineer | Human, Cynomolgus Monkey | Recombinate | inhibition, neutralization, SPR, ELISA |
Anti-IL-13 mAbs [13-62](MABL-2026) | MABL-2026 | Engineer | Human | Recombinate | ELISA |
Anti-IL-12RB2 mAbs [IL12Rb2#2](MABL-2025) | MABL-2025 | Engineer | Human | Recombinate | FACS, inhibition, SPR, ELISA |
Anti-IL-12RB2 mAbs [IL12Rb2#1](MABL-2024) | MABL-2024 | Engineer | Human | Recombinate | FACS, inhibition, SPR, ELISA |
Anti-IL-12/IL-23p40 mAbs [CNTO 1275 (Ustekinumab)](MABL-2023) | MABL-2023 | Engineer | Human | Recombinate | in vivo, therapeutic, Block |
Anti-IL-12 mAbs [7G11](MABL-2022) | MABL-2022 | Engineer | Human | Recombinate | ELISA |
Anti-IL-12 mAbs [12E3](MABL-2021) | MABL-2021 | Engineer | Human | Recombinate | ELISA |
Anti-IL-10R mAbs [1B1.3a](MABL-2020) | MABL-2020 | Engineer | Mouse | Recombinate | Blocking, FC |
Anti-IL-10 mAbs [JES3-9D7](MABL-2019) | MABL-2019 | Engineer | Baboon, Cynomolgus, Rhesus, Human | Recombinate | Cytokine Neutralization Assay, ELISpot capture antibody, IHC-P, WB, ELISA |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn